Seeking Prostate Cancer Survivors for Technology Discussion
Thanks to Lesly Maranan, for passing this along!
From the desk of Dan Ollendorf, MPH, ARM, Chief Review Officer, Institute for Clinical & Economic Review
I am writing concerning the efforts of a new initiative known as the Institute for Clinical & Economic Review (ICER), a new initiative of Harvard Medical School, that seeks to provide an impartial review of new or emerging healthcare technologies that involves ALL relevant stakeholders (including patients). We are currently evaluating permanent brachytherapy and proton beam therapy for prostate cancer, and would like to include patients who have undergone each of these treatments in our discussion.
Tina Radcliffe spent ten years as a Oncology Certified R.N. working with in-patients on oncology and med-surg units. She also has a background in home health and geriatrics. Her other experiences include ... .. 
